Korea seeks mutual recognition arrangement on preclinical data with OECD

Published: 2010-05-17 06:58:00

Updated: 2010-05-17 06:58:00

Korea will receive an on-site evaluation of the Organization for Economic Cooperation and Development (OECD) to seek a mutual recognition arrangement (MRA) on preclinical data among member states.

The MRA is particular meaningful to the country, which has been seeking the enhancement of GLP (G...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK